PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsBronchial spasm
MeSH D001986 - bronchial spasm
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001982:Bronchial diseases
0 Companies
0 Drugs
Success rate
D001986: 
Bronchial spasm
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaSalmeterol, Fluticasone Aerivio Spiromax  2016-08-18   
Salmeterol xinafoate, Fluticasone Airduo 2023-05-06 2017-01-27   
Salmeterol xinafoate, Fluticasone Airexar Spiromax  2016-08-18   
Albuterol Albuterol  1989-12-05   
Albuterol, Ipratropium Albuterol Ipratropium  2007-12-31   
Arformoterol Arformoterol  2021-11-09   
Budesonide, Formoterol BiResp Spiromax  2014-04-28   
Salmeterol, Fluticasone BroPair Spiromax  2021-03-26   
Budesonide, Formoterol Budesonide/Formoterol Teva  2014-11-19   
Budesonide, Formoterol DuoResp Spiromax  2014-04-28   
Epinephrine Epinephrine  2018-08-16   
Salmeterol xinafoate, Fluticasone Fluticasone Salmeterol Xinafoate  2021-12-13   
Formoterol Formoterol  2021-06-22   
Albuterol Proair 2023-09-12 2004-10-29 $180 M Y2021 
Salmeterol, Fluticasone Seffalair Spiromax  2021-03-26   
Budesonide, Formoterol Vylaer Spiromax  2014-11-19   
Budesonide, Formoterol Budesonide/Formoterol Teva Pharma B.V  2014-11-19   
Levalbuterol Levalbuterol  2013-04-26   
PadagisAlbuterol Albuterol  2020-02-24   
Glenmark PharmaceuticalsArformoterol Arformoterol  2021-06-22   
MylanAlbuterol Accuneb  2001-04-30   
Albuterol Albuterol  1992-02-21   
Albuterol, Ipratropium bromide Duoneb  2001-03-21   
Salmeterol xinafoate, Fluticasone Wixela  2019-01-30   
Budesonide, Formoterol Breyna  2022-03-15   
Levalbuterol Levalbuterol  2013-03-15   
ViatrisEpinephrine Epi 2025-09-11 1987-12-22   
Formoterol Perforomist  2007-05-11   
Rising PharmaceuticalsAlbuterol Albuterol  2007-01-29   
1
2
3
4
5
6
...
16
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
71%
5/7
Phase 3
83%
19/23
Approved: 18Overall Success rate: 59%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Johnson & Johnson
1
2
3
4
5
6
...
11
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use